Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00482807
What this trial is testing

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Nebraska 9
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Early research (Phase 1)Study completedNCT00372736
What this trial is testing

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 27
Not applicableActive Not RecruitingNCT07018427
What this trial is testing

Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Who this might be right for
Breast NeoplasmsTriple Negative Breast CancerHR+, HER2-, Advanced Breast Cancer+1 more
Peking University Cancer Hospital & Institute 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07555860
What this trial is testing

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Testing effectiveness (Phase 2)WithdrawnNCT01349088
What this trial is testing

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancerStage IV Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)UnknownNCT01180166
What this trial is testing

Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer

Who this might be right for
Gastric CancerConcurrent Chemoradiotherapy
Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808515
What this trial is testing

A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Regeneron Pharmaceuticals 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07835789
What this trial is testing

Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer

Who this might be right for
Locally Recurrent Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
NRG Oncology 138
Testing effectiveness (Phase 2)Study completedNCT03008278
What this trial is testing

Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Esophageal CarcinomaMetastatic Gastric CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+10 more
National Cancer Institute (NCI) 51
Early research (Phase 1)WithdrawnNCT05010096
What this trial is testing

BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00851136
What this trial is testing

PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 9
Early research (Phase 1)Ended earlyNCT02933944
What this trial is testing

Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer

Who this might be right for
Rectal Cancer
Targovax ASA 6
Testing effectiveness (Phase 2)Ended earlyNCT00005072
What this trial is testing

Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Vical 25
Testing effectiveness (Phase 2)Looking for participantsNCT07632339
What this trial is testing

Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 102
Not applicableActive Not RecruitingNCT02560181
What this trial is testing

Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Sunnybrook Health Sciences Centre 30
Not applicableStudy completedNCT03350529
What this trial is testing

MRI Guided Transurethral HIFU for Various Prostate Diseases

Who this might be right for
Localised Prostate CancerLocally Advanced Prostate CancerLocally Recurrent Prostate Cancer+1 more
Turku University Hospital 87
Early research (Phase 1)Ended earlyNCT02110992
What this trial is testing

Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
University of Cincinnati 7
Testing effectiveness (Phase 2)Study completedNCT00085475
What this trial is testing

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 17
Testing effectiveness (Phase 2)Ended earlyNCT00356681
What this trial is testing

AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

Who this might be right for
Breast NeoplasmsBreast TumorsBreast Cancer+1 more
Amgen 282
Next Page